Return
Genetic algorithms and parallel processing in maximum-likelihood phylogeny inference
DOI:10.1093/oxfordjournals.molbev.a003994.png)
Abstract
En 中文
We investigated the usefulness of a parallel genetic algorithm for phylogenetic inference under the maximum-likelihood (NIL) optimality criterion. Parallelization was accomplished by assigning each individual in the genetic algorithm population to a separate processor so that the number of processors used was equal to the size of the evolving population (plus one additional processor for the control of operations). The genetic algorithm incorporated branch-length and topological mutation, recombination, selection on the ML score, and (in some cases) migration and recombination among subpopulations. We tested this parallel genetic algorithm with large (228 taxa) data sets of both empirically observed DNA sequence data (for angiosperms) as well as simulated DNA sequence data. For both observed and simulated data, search-time improvement was nearly linear with respect to the number of processors, so the parallelization strategy appears to be highly effective at improving computation time for large phylogenetic problems using the genetic algorithm. We also explored various ways of optimizing and tuning the parameters of the genetic algorithm. Under the conditions of our analyses, we did not find the best-known solution using the genetic algorithm approach before terminating each run. We discuss some possible limitations of the current implementation of this genetic algorithm as well as of avenues for its future improvement.
Keywords:
genetic algorithm
phylogeny inference
maximum likelihood
parallel algorithm
nucleotide sequence data
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
5.3
Papers:
8.4K
Citations:
6.6W
Organization
No organization information available
Cited Papers
Endogenous TPO (eTPO) levels in health and disease: Possible clues for therapeutic intervention
Stem Cells
IF0

